We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+13.38%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$106M
(-9.2%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-16.63%
Top 10 Holdings %
Top 10 Hldgs %
5.73%
Holding
1,387
New
364
Increased
246
Reduced
349
Closed
422
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$5.05M |
| 2 |
Century Aluminum
CENX
|
+$4.6M |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$4.54M |
| 4 |
BBBY
Bed Bath & Beyond
BBBY
|
+$4.51M |
| 5 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$4.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OneSpan
OSPN
|
+$7.67M |
| 2 |
Lattice Semiconductor
LSCC
|
+$7.09M |
| 3 |
Mercury Insurance
MCY
|
+$5.38M |
| 4 |
Omnicell
OMCL
|
+$5.15M |
| 5 |
Maximus
MMS
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.11% |
| 2 | Technology | 14.11% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Ducommun
DCO
$2.68B
| $1.3M | 0.12% |
51,270
+4,316
| +9% | +$112K |
|
|
NOR
252
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
| $1.3M | 0.12% |
52,601
-25,032
| -32% | -$675K |
|
|
MWW
253
DELISTED
Monster Worldwide Inc
MWW
| $1.3M | 0.12% |
280,448
-520,305
| -65% | -$2.29M |
|
|
ALDR
254
DELISTED
Alder Biopharmaceuticals
ALDR
| $1.29M | 0.12% |
44,505
+22,033
| +98% | +$395K |
|
255
Mistras Group
MG
$488M
| $1.29M | 0.12% |
+70,141
| New | +$1.2M |
|
|
PERY
256
DELISTED
Perry Ellis International Inc
PERY
| $1.27M | 0.12% |
48,933
-6,490
| -12% | -$149K |
|
|
BELFB
257
Bel Fuse Inc Class B
BELFB
$3.65B
| $1.27M | 0.12% |
46,302
-4,661
| -9% | -$122K |
|
|
SCAI
258
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $1.27M | 0.12% |
37,613
+25,236
| +204% | +$777K |
|
|
WRI
259
DELISTED
Weingarten Realty Investors
WRI
| $1.26M | 0.12% |
+36,001
| New | +$1.25M |
|
|
CVG
260
DELISTED
Convergys
CVG
| $1.25M | 0.12% |
61,445
+22,239
| +57% | +$441K |
|
|
BDN
261
Brandywine Realty Trust
BDN
$539M
| $1.25M | 0.12% |
78,017
-36,122
| -32% | -$549K |
|
|
ASCMA
262
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $1.24M | 0.12% |
23,462
-1,091
| -4% | -$62.8K |
|
263
National Bank Holdings
NBHC
$1.91B
| $1.24M | 0.12% |
63,702
+29,317
| +85% | +$564K |
|
|
PKY
264
DELISTED
Parkway, Inc.
PKY
| $1.24M | 0.12% |
67,175
+47,920
| +249% | +$913K |
|
265
Universal Insurance Holdings
UVE
$1.21B
| $1.23M | 0.12% |
60,246
-3,842
| -6% | -$67.1K |
|
|
VSI
266
DELISTED
Vitamin Shoppe Inc.
VSI
| $1.23M | 0.12% |
+25,331
| New | +$1.16M |
|
|
PRA
267
DELISTED
ProAssurance
PRA
| $1.23M | 0.12% |
27,224
-713
| -3% | -$32.6K |
|
268
Hyster-Yale Materials Handling
HY
$591M
| $1.22M | 0.12% |
16,702
+4,969
| +42% | +$370K |
|
269
The GEO Group
GEO
$4.14B
| $1.22M | 0.12% |
45,419
+11,931
| +36% | +$311K |
|
|
SHLM
270
DELISTED
Schulman (A.) Inc
SHLM
| $1.22M | 0.12% |
30,068
+11,428
| +61% | +$413K |
|
271
Pegasystems
PEGA
$4.85B
| $1.22M | 0.12% |
117,042
-126,810
| -52% | -$1.3M |
|
|
DENN
272
DELISTED
Denny's
DENN
| $1.21M | 0.12% |
117,733
+94,304
| +403% | +$836K |
|
273
Stewart Information Services
STC
$2.04B
| $1.21M | 0.12% |
+32,784
| New | +$1.11M |
|
|
MENT
274
DELISTED
Mentor Graphics Corp
MENT
| $1.21M | 0.12% |
55,255
-119,546
| -68% | -$2.52M |
|
275
Delek US
DK
$3.89B
| $1.21M | 0.12% |
44,373
+10,318
| +30% | +$312K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2014 Portfolio in Review
As of Q4 2014, TFS Capital held 1,387 positions worth $1.05B, down 9.2% from $1.15B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
TFS Capital withdrew a net $174M in Q4 2014, closing 422 positions and reducing 349 holdings. Its most notable exit was Lattice Semiconductor, an estimated $7.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TFS Capital opened a new position in Infinity Pharmaceuticals, Inc. worth $5.86M.
- TFS Capital's largest Q4 2014 buy was Infinity Pharmaceuticals, Inc.: 347,088 shares worth $5.86M.
- TFS Capital added most to Cambrex Corporation in Q4 2014, an estimated $4.54M increase.
- TFS Capital's biggest Q4 2014 reduction was OneSpan, cutting an estimated $7.67M.
- TFS Capital fully exited Lattice Semiconductor in Q4 2014, selling an estimated $7.09M.
- TFS Capital's ten largest holdings make up 5.7% of its $1.05B portfolio in Q4 2014.
- TFS Capital opened 364 new positions and closed 422 in Q4 2014.
- TFS Capital's portfolio value fell 9.2% quarter-over-quarter to $1.05B.
Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.